Skip to main content
Top
Published in: International Ophthalmology 5/2022

02-12-2021 | Streptococci | Original Paper

Endophthalmitis panorama in the Jerusalem area

Authors: Juan Martin Sanchez, Hila Elinav, Liran Tiosano, Radgonde Amer

Published in: International Ophthalmology | Issue 5/2022

Login to get access

Abstract

Purpose

The spectrum of microbial infections and the pattern of their susceptibility are variable among communities. Researching these data will lead to the establishment of the most appropriate national management strategies. The purpose of this study was to analyze the epidemiological, clinical, microbial spectrum and antibiotic susceptibility of endophthalmitis cases in a tertiary referral center in Jerusalem.

Methods

Retrospective review of medical charts of patients presenting with endophthalmitis over a 12-year period.

Results

A total of 74 eyes of 70 patients (males 56%) were included. Mean age ± SD at presentation was 60 ± 19.5 years. Exogenous endophthalmitis accounted for 78% of cases, of which 62% followed an intraocular surgery, 21% occurred after intravitreal injections, 10% followed infectious keratitis and 7% were posttraumatic. Endogenous cases were predominantly observed in diabetic patients. Microbial isolates were identified in 44 samples. Of them, gram-positive bacteria were the predominant microorganisms detected in 33 samples (75%); Staphylococcus epidermidis and Enterococcus faecalis were the most commonly detected pathogens.
Mean presenting ± SD LogMAR visual acuity (VA) was 2.38 ± 1.21 and it improved at last follow-up to 1.7 ± 1.37 (p = 0.004, paired t test). Cases secondary to gram-positive microbes were associated with improved VA during the follow-up while cases secondary to gram-negative microbes was correlated with poor final VA (p = 0.046, r2 = 0.4). There was no evidence of bacterial resistance in the antibiograms for either vancomycin, ceftazidime, ceftriaxone or amikacin.

Conclusions

Intraocular surgery remains the most common event preceding endophthalmitis with coagulase-negative staphylococci being the most frequently detected microorganisms. The microbial spectrum of endophthalmitis is similar to that in the western world.
Literature
1.
go back to reference Han DP, Wisniewski SR, Wilson LA, Barza M, Vine AK, Doft BH, Kelsey SF (1996) Spectrum and susceptibilities of microbiologic isolates in the endophthalmitis vitrectomy study. Am J Ophthalmol 122(1):1–17CrossRef Han DP, Wisniewski SR, Wilson LA, Barza M, Vine AK, Doft BH, Kelsey SF (1996) Spectrum and susceptibilities of microbiologic isolates in the endophthalmitis vitrectomy study. Am J Ophthalmol 122(1):1–17CrossRef
2.
go back to reference Liu C, Ji J, Li S, Wang Z, Tang L, Cao W, Sun X (2017) Microbiological isolates and antibiotic susceptibilities: a 10-year review of culture-proven endophthalmitis cases. Curr Eye Res 42(3):443–447CrossRef Liu C, Ji J, Li S, Wang Z, Tang L, Cao W, Sun X (2017) Microbiological isolates and antibiotic susceptibilities: a 10-year review of culture-proven endophthalmitis cases. Curr Eye Res 42(3):443–447CrossRef
3.
go back to reference Gentile RC, Shukla S, Shah M, Ritterband DC, Engelbert M, Davis A, Hu DN (2014) Microbiological spectrum and antibiotic sensitivity in endophthalmitis: a 25-year review. Ophthalmology 121(8):1634–1642CrossRef Gentile RC, Shukla S, Shah M, Ritterband DC, Engelbert M, Davis A, Hu DN (2014) Microbiological spectrum and antibiotic sensitivity in endophthalmitis: a 25-year review. Ophthalmology 121(8):1634–1642CrossRef
4.
go back to reference Schimel AM, Miller D, Flynn HW Jr (2013) Endophthalmitis isolates and antibiotic susceptibilities: A 10-year review of culture-proven cases. Am J Ophthalmol 156(1):50-52.e1CrossRef Schimel AM, Miller D, Flynn HW Jr (2013) Endophthalmitis isolates and antibiotic susceptibilities: A 10-year review of culture-proven cases. Am J Ophthalmol 156(1):50-52.e1CrossRef
5.
go back to reference Satpathy G, Nayak N, Wadhwani M, Venkwatesh P, Kumar A, Sharma Y, Sreenivas V (2017) Clinicomicrobiological profile of endophthalmitis: A 10 year experience in a tertiary care center in north India. Indian J Pathol Microbiol 60(2):214–220CrossRef Satpathy G, Nayak N, Wadhwani M, Venkwatesh P, Kumar A, Sharma Y, Sreenivas V (2017) Clinicomicrobiological profile of endophthalmitis: A 10 year experience in a tertiary care center in north India. Indian J Pathol Microbiol 60(2):214–220CrossRef
6.
go back to reference Lin L, Duan F, Yang Y, Lou B, Liang L, Lin X (2019) Nine-year analysis of isolated pathogens and antibiotic susceptibilities of microbial keratitis from a large referral eye center in southern China. Infect Drug Resist 12:1295–1302CrossRef Lin L, Duan F, Yang Y, Lou B, Liang L, Lin X (2019) Nine-year analysis of isolated pathogens and antibiotic susceptibilities of microbial keratitis from a large referral eye center in southern China. Infect Drug Resist 12:1295–1302CrossRef
7.
go back to reference Endophthalmitis Vitrectomy Study Group (1996) Microbiologic factors and visual outcome in the endophthalmitis vitrectomy study. Am J Ophthalmol 122(6):830–846CrossRef Endophthalmitis Vitrectomy Study Group (1996) Microbiologic factors and visual outcome in the endophthalmitis vitrectomy study. Am J Ophthalmol 122(6):830–846CrossRef
8.
go back to reference Moloney TP, Park J (2014) Pseudallescheria endophthalmitis: four cases over 15 years in Queensland, Australia, and a review of the literature. Retina 34(8):1683–1701CrossRef Moloney TP, Park J (2014) Pseudallescheria endophthalmitis: four cases over 15 years in Queensland, Australia, and a review of the literature. Retina 34(8):1683–1701CrossRef
9.
go back to reference Tadros TS, Workowski KA, Siegel RJ, Hunter S, Schwartz DA (1998) Pathology of hyalohyphomycosis caused by Scedosporium apiospermum (Pseudallescheria boydii): an emerging mycosis. Hum Pathol 29:1266–1272CrossRef Tadros TS, Workowski KA, Siegel RJ, Hunter S, Schwartz DA (1998) Pathology of hyalohyphomycosis caused by Scedosporium apiospermum (Pseudallescheria boydii): an emerging mycosis. Hum Pathol 29:1266–1272CrossRef
10.
go back to reference O’Bryan TA (2005) Pseudallescheriasis in the 21st century. Expert Rev Anti Infect Ther 3:765–773CrossRef O’Bryan TA (2005) Pseudallescheriasis in the 21st century. Expert Rev Anti Infect Ther 3:765–773CrossRef
11.
go back to reference Guarro J, Kantarcioglu AS, Horré R, Rodriguez-Tudela JL, Cuenca Estrella M, Berenguer J et al (2006) Scedosporium apiospermum: changing clinical spectrum of a therapy-refractory opportunist. Med Mycol 44:295–327CrossRef Guarro J, Kantarcioglu AS, Horré R, Rodriguez-Tudela JL, Cuenca Estrella M, Berenguer J et al (2006) Scedosporium apiospermum: changing clinical spectrum of a therapy-refractory opportunist. Med Mycol 44:295–327CrossRef
12.
go back to reference Ender PT, Dolan MJ (1997) Pneumonia associated with near-drowning. Clin Infect Dis 25:896–907CrossRef Ender PT, Dolan MJ (1997) Pneumonia associated with near-drowning. Clin Infect Dis 25:896–907CrossRef
13.
go back to reference Abulafia A, Rosen E, Assia EI, Kleinmann G (2015) Establishment of a registry to monitor trends in cataract surgical procedures and outcomes in Israel, 1990–2014. Isr Med Assoc J 17(12):755–759PubMed Abulafia A, Rosen E, Assia EI, Kleinmann G (2015) Establishment of a registry to monitor trends in cataract surgical procedures and outcomes in Israel, 1990–2014. Isr Med Assoc J 17(12):755–759PubMed
14.
go back to reference Endophthalmitis Study Group, European Society of Cataract & Refractive Surgeons (2007) Prophylaxis of postoperative endophthalmitis following cataract surgery: results of the ESCRS multicenter study and identification of risk factors. J Cataract Refract Surg 33:978–988CrossRef Endophthalmitis Study Group, European Society of Cataract & Refractive Surgeons (2007) Prophylaxis of postoperative endophthalmitis following cataract surgery: results of the ESCRS multicenter study and identification of risk factors. J Cataract Refract Surg 33:978–988CrossRef
15.
go back to reference Schwartz SG, Flynn HW Jr, Scott IU (2009) Endophthalmitis after intravitreal injections. Expert Opin Pharmacother 10:1–8CrossRef Schwartz SG, Flynn HW Jr, Scott IU (2009) Endophthalmitis after intravitreal injections. Expert Opin Pharmacother 10:1–8CrossRef
16.
go back to reference Dar N, Pillar S, Friehmann A, Belkin A, Ofir S (2020) Endophthalmitis after intravitreal injections versus cataract surgery: a 15-year cohort. Int Ophthalmol 40:73–79CrossRef Dar N, Pillar S, Friehmann A, Belkin A, Ofir S (2020) Endophthalmitis after intravitreal injections versus cataract surgery: a 15-year cohort. Int Ophthalmol 40:73–79CrossRef
17.
go back to reference Simunovic MP, Rush RB, Hunyor AP, Chang AA (2012) Endophthalmitis following intravitreal injection versus endophthalmitis following cataract surgery: clinical features, causative organisms and post-treatment outcomes. Br J Ophthalmol 96:862–866CrossRef Simunovic MP, Rush RB, Hunyor AP, Chang AA (2012) Endophthalmitis following intravitreal injection versus endophthalmitis following cataract surgery: clinical features, causative organisms and post-treatment outcomes. Br J Ophthalmol 96:862–866CrossRef
18.
go back to reference McCannel CA (2011) Meta-analysis of endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents: causative organisms and possible prevention strategies. Retina 201(31):654–661CrossRef McCannel CA (2011) Meta-analysis of endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents: causative organisms and possible prevention strategies. Retina 201(31):654–661CrossRef
19.
go back to reference Vaziri K, Schwartz SG, Kishor K, Flynn HW Jr (2015) Endophthalmitis: state of the art. Clin Ophthalmol (Auckland, NZ) 9:95–108 Vaziri K, Schwartz SG, Kishor K, Flynn HW Jr (2015) Endophthalmitis: state of the art. Clin Ophthalmol (Auckland, NZ) 9:95–108
20.
go back to reference Maalouf F, Abdulaal M, Hamam RN (2012) Chronic postoperative endophthalmitis: a review of clinical characteristics, microbiology, treatment strategies, and outcomes. Int J Inflam 2012:313248PubMedPubMedCentral Maalouf F, Abdulaal M, Hamam RN (2012) Chronic postoperative endophthalmitis: a review of clinical characteristics, microbiology, treatment strategies, and outcomes. Int J Inflam 2012:313248PubMedPubMedCentral
21.
go back to reference Ohtomo K, Mayama C, Ueta T, Nagahara M (2015) Outcomes of late-onset bleb-related endophthalmitis treated with pars plana vitrectomy. J Ophthalmol 2015:923857CrossRef Ohtomo K, Mayama C, Ueta T, Nagahara M (2015) Outcomes of late-onset bleb-related endophthalmitis treated with pars plana vitrectomy. J Ophthalmol 2015:923857CrossRef
22.
go back to reference Yamamoto T, Sawada A, Mayama C et al (2014) The 5-year incidence of bleb-related infection and its risk factors after filtering surgeries with adjunctive mitomycin C: collaborative bleb-related infection incidence and treatment study 2. Ophthalmology 121(5):1001–1006CrossRef Yamamoto T, Sawada A, Mayama C et al (2014) The 5-year incidence of bleb-related infection and its risk factors after filtering surgeries with adjunctive mitomycin C: collaborative bleb-related infection incidence and treatment study 2. Ophthalmology 121(5):1001–1006CrossRef
23.
go back to reference Mochizuki K, Jikihara S, Ando Y, Hori N, Yamamoto T, Kitazawa Y (1997) Incidence of delayed onset infection after trabeculectomy with adjunctive mitomycin C or 5-fluorouracil treatment. Br J Ophthalmol 81(10):877–883CrossRef Mochizuki K, Jikihara S, Ando Y, Hori N, Yamamoto T, Kitazawa Y (1997) Incidence of delayed onset infection after trabeculectomy with adjunctive mitomycin C or 5-fluorouracil treatment. Br J Ophthalmol 81(10):877–883CrossRef
24.
go back to reference Song A, Scott IU, Flynn HW Jr, Budenz DL (2002) Delayed-onset bleb-associated endophthalmitis: clinical features and visual acuity outcomes. Ophthalmology 109(5):985–991CrossRef Song A, Scott IU, Flynn HW Jr, Budenz DL (2002) Delayed-onset bleb-associated endophthalmitis: clinical features and visual acuity outcomes. Ophthalmology 109(5):985–991CrossRef
25.
go back to reference Brockhaus L, Goldblum D, Eggenschwiler L, Zimmerli S, Marzolini C (2019) Revisiting systemic treatment of bacterial endophthalmitis: a review of intravitreal penetration of systemic antibiotics. Clin Microbiol Infect 25(11):1364–1369CrossRef Brockhaus L, Goldblum D, Eggenschwiler L, Zimmerli S, Marzolini C (2019) Revisiting systemic treatment of bacterial endophthalmitis: a review of intravitreal penetration of systemic antibiotics. Clin Microbiol Infect 25(11):1364–1369CrossRef
26.
go back to reference López-CabezasC MDS, Massa MR, Mensa Pueyo JM (2010) Antibiotics in endophthalmitis: microbiological and pharmacokinetic considerations. Curr Clin Pharmacol 5(1):47–54CrossRef López-CabezasC MDS, Massa MR, Mensa Pueyo JM (2010) Antibiotics in endophthalmitis: microbiological and pharmacokinetic considerations. Curr Clin Pharmacol 5(1):47–54CrossRef
27.
go back to reference Jay WM, Aziz MZ, Rissing JP, Shockley RK (1985) Pharmacokinetic analysis of intravitreal ceftriaxone in monkeys. Arch Ophthalmol 103(1):121–123CrossRef Jay WM, Aziz MZ, Rissing JP, Shockley RK (1985) Pharmacokinetic analysis of intravitreal ceftriaxone in monkeys. Arch Ophthalmol 103(1):121–123CrossRef
28.
go back to reference Shockley RK, Jay WM, Friberg TR, Aziz AM, Rissing JP, Aziz MZ (1984) Intravitreal ceftriaxone in a rabbit model. Dose- and time-dependent toxic effects and pharmacokinetic analysis. Arch Ophthalmol 102(8):1236–1238CrossRef Shockley RK, Jay WM, Friberg TR, Aziz AM, Rissing JP, Aziz MZ (1984) Intravitreal ceftriaxone in a rabbit model. Dose- and time-dependent toxic effects and pharmacokinetic analysis. Arch Ophthalmol 102(8):1236–1238CrossRef
29.
go back to reference Marquart ME, Benton AH, Galloway RC, Stempak LS (2018) Antibiotic susceptibility, cytotoxicity, and protease activity of viridans group streptococci causing endophthalmitis. PLoS One 13(12):e0209849CrossRef Marquart ME, Benton AH, Galloway RC, Stempak LS (2018) Antibiotic susceptibility, cytotoxicity, and protease activity of viridans group streptococci causing endophthalmitis. PLoS One 13(12):e0209849CrossRef
31.
go back to reference Luaces-Rodríguez A, González-Barcia M, Blanco-Teijeiro MJ, Gil-Martínez M, Gonzalez F, Gómez-Ulla F, Lamas MJ, Otero-Espinar FJ, Fernández-Ferreiro A (2018) Review of intraocular pharmacokinetics of anti-infectives commonly used in the treatment of infectious endophthalmitis. Pharmaceutics 10(2):66CrossRef Luaces-Rodríguez A, González-Barcia M, Blanco-Teijeiro MJ, Gil-Martínez M, Gonzalez F, Gómez-Ulla F, Lamas MJ, Otero-Espinar FJ, Fernández-Ferreiro A (2018) Review of intraocular pharmacokinetics of anti-infectives commonly used in the treatment of infectious endophthalmitis. Pharmaceutics 10(2):66CrossRef
Metadata
Title
Endophthalmitis panorama in the Jerusalem area
Authors
Juan Martin Sanchez
Hila Elinav
Liran Tiosano
Radgonde Amer
Publication date
02-12-2021
Publisher
Springer Netherlands
Published in
International Ophthalmology / Issue 5/2022
Print ISSN: 0165-5701
Electronic ISSN: 1573-2630
DOI
https://doi.org/10.1007/s10792-021-02142-z

Other articles of this Issue 5/2022

International Ophthalmology 5/2022 Go to the issue